1 elevated potassium levels were associated with an increased mortality risk, which is noteworthy because this association in the general population (as opposed to those with chronic kidney disease or coronary artery disease 2 ) has been infrequently investigated. For the purposes of complementing, replicating, and potentially expanding the generalizability of the findings of Chen et al, we investigated the potassium-mortality relationship in the general population of the United States. Further, we explore this topic among other subpopulations, adding additional novelty to this study.
Study Population. Data from the 1999-2006 National Health and Nutrition Examination Survey were employed, with follow-up through 2011. After excluding those with a diagnosis of coronary artery disease, congestive heart failure, myocardial infarction, stroke, or cancer, 14,016 participants (aged 20-85 years) constituted our sample; 1160 died over the follow-up period. The median follow-up was 104 months (interquartile range, 80-128 months). The mean (SE) potassium level was 4.02 (0.01) mmol/L, and the mean age was 43.3 (0.2) years.
Results. In a Cox proportional hazards model, after adjusting for age, sex, race/ethnicity, measured body mass index, resting heart rate, selfreported physical activity, smoking Discussion. Limitations of this study include the one time-point assessment of potassium and not evaluating modifying effects of potassiumaltering medications, but this latter point has already been addressed. 1 The results from this National Health and Nutrition Examination Survey cohort align with those from the ARIC cohort.
1 Although higher potassium levels within the normal range may be beneficial, particularly among patients with cardiovascular disease, 4 our findings coupled with those of Chen et al 1 illustrate that potassium levels outside this normal range, especially those above the normal range, may increase mortality risk in the general and cardiac populations. These collective findings suggest the importance of clinician monitoring of patient potassium levels among the general population.
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